The chemical substance known as (5Z,9R,11R,15R)-9-Chloro-15-cyclohexyl-11,15-dihydroxy-3-oxa-16,17,18,19,20-pentanorprosta-5-enoic acid isopropyl ester, with CAS number 170291-06-2, is a synthetic compound that belongs to the class of prostaglandin analogs. It features a complex structure characterized by multiple stereocenters, which contribute to its specific biological activity. The presence of a chloro group and hydroxyl groups indicates potential reactivity and solubility properties, while the isopropyl ester moiety suggests enhanced lipophilicity, which may influence its pharmacokinetics. This compound is likely to exhibit specific interactions with biological receptors, making it of interest in pharmaceutical research, particularly in the context of inflammatory or cardiovascular conditions. Its structural features, including the cyclohexyl group and the unique oxabicyclic framework, may also play a role in modulating its therapeutic effects. Overall, this compound represents a significant area of study for its potential applications in medicine.

(5Z,9R,11R,15R)-9-Chloro-15-cyclohexyl-11,15-dihydroxy-3-oxa-16,17,18,19,20-pentanorprosta-5-enoic acid isopropyl ester

170291-06-2: The chemical substance known as (5Z,9R,11R,15R)-9-Chloro-15-cyclohexyl-11,15-dihydroxy-3-oxa-16,17,18,19,20-pentanorprosta-5-enoic acid isopropyl ester, with CAS number 170291-06-2, is a synthetic compound that belongs to the class of prostaglandin analogs. It features a complex structure characterized by multiple stereocenters, which contribute to its specific biological activity. The presence of a chloro group and hydroxyl groups indicates potential reactivity and solubility properties, while the isopropyl ester moiety suggests enhanced lipophilicity, which may influence its pharmacokinetics. This compound is likely to exhibit specific interactions with biological receptors, making it of interest in pharmaceutical research, particularly in the context of inflammatory or cardiovascular conditions. Its structural features, including the cyclohexyl group and the unique oxabicyclic framework, may also play a role in modulating its therapeutic effects. Overall, this compound represents a significant area of study for its potential applications in medicine.

<p>AL 6598, a prodrug of PGD2 agonist AL 6556, reduces IOP by 53% at 1μg twice daily in monkeys; binds DP receptors with Ki of 3.2μM.</p>

CAS 170291-06-2

(5Z,9R,11R,15R)-9-Chloro-15-cyclohexyl-11,15-dihydroxy-3-oxa-16,17,18,19,20-pentanorprosta-5-enoic acid isopropyl ester

AL 6598

Ref: TM-T38113